Publications
2 shownEnzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Enzalutamide was associated with significantly longer progression-free and overall survival than standard care in men with metastatic, hormone-sensitive prostate cancer receivin...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,249
- Institution
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
External Links
Identifiers
- ORCID
- 0000-0002-1357-0884
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.